Litcius/Paper detail

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer

Hiroyuki Arai, Andrew Elliott, Joshua Millstein, Joanne Xiu, Fang‐Shu Ou, Federico Innocenti, Jingyuan Wang, Francesca Battaglin, Priya Jayachandran, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Davendra Sohal, Richard M. Goldberg, Michael J. Hall, Aaron J. Scott, Moh’d Khushman, Jimmy J. Hwang, Emil Lou, Benjamin A. Weinberg, A. Craig Lockhart, Anthony F. Shields, Jim Abraham, Daniel Magee, Phillip Stafford, Jian Zhang, Alan P. Venook, W. Michael Korn, Heinz‐Josef Lenz

2021Oncogene22 citationsDOIOpen Access PDF

Topics & Concepts

Neurofibromin 1BiologyColorectal cancerPTENKRASCancer researchGene expression profilingOncologyCancerCDKN2AInternal medicineNeurofibromatosisPI3K/AKT/mTOR pathwayGene expressionMedicineGeneticsGeneSignal transductionNeurofibromatosis and Schwannoma CasesColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology Research
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer | Litcius